BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26223969)

  • 21. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
    Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
    Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day +30 after allo-HSCT.
    Drokov MY; Davydova JO; Kuzmina LA; Galtseva IV; Kapranov NM; Vasilyeva VA; Dubnyak DS; Koroleva OM; Mikhalcova ED; Popova NN; Parovichnikova EN; Savchenko VG
    Leuk Res; 2017 Mar; 54():25-29. PubMed ID: 28095351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of exercise interventions in graft-versus-host disease models.
    Fiuza-Luces C; González-Murillo A; Soares-Miranda L; Martínez Palacio J; Colmenero I; Casco F; Melén G; Morán M; Lucia A; Ramírez M
    Cell Transplant; 2013; 22(12):2409-20. PubMed ID: 23127525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
    Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical characteristics of acute graft-versus-host disease confined solely to gastrointestinal tract after allogeneic hematopoietic stem cell transplantation].
    Feng R; Liu DH; Xu LP; Chen H; Zhang XH; Han W; Zhao T; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1028-31. PubMed ID: 21211361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].
    Chen YH; Huang XJ; Guo NL; Ren HY; Zhang YC; Xu LP; Gao ZY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):61-3. PubMed ID: 12697096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.
    He X; Ye Y; Xu X; Wang J; Huang Y; Weng G; Zhang M; Guo K
    Biomed Res Int; 2016; 2016():3071214. PubMed ID: 27843940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.
    Couturier M; Lamarthée B; Arbez J; Renauld JC; Bossard C; Malard F; Bonnefoy F; Mohty M; Perruche S; Tiberghien P; Saas P; Gaugler B
    Leukemia; 2013 Jul; 27(7):1527-37. PubMed ID: 23399894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.
    Bäuerlein CA; Riedel SS; Baker J; Brede C; Garrote AL; Chopra M; Ritz M; Beilhack GF; Schulz S; Zeiser R; Schlegel PG; Einsele H; Negrin RS; Beilhack A
    BMC Med; 2013 May; 11():134. PubMed ID: 23692886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease.
    Zitzer NC; Garzon R; Ranganathan P
    Front Immunol; 2018; 9():2561. PubMed ID: 30455702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
    Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease.
    Crossland RE; Norden J; Juric MK; Green K; Pearce KF; Lendrem C; Greinix HT; Dickinson AM
    Front Immunol; 2017; 8():308. PubMed ID: 28392786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
    Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
    Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
    Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
    Yin J; Li L; Wang C; Zhang Y
    Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Heme Oxygenase-1 as a Novel Predictor of Hematopoietic Stem Cell Transplantation Outcomes in Acute Leukemia.
    Lu Y; Wu D; Wang J; Li Y; Ma D; Chai X; Kang Q
    Cell Physiol Biochem; 2016; 39(4):1495-502. PubMed ID: 27606430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential Genes Mediate the Pathogenicity of Allogeneic CD4
    Yu Z; Qin C; Cao M; He X; Ren H; Liu H
    Biomed Res Int; 2021; 2021():9958745. PubMed ID: 34036106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.